Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448545) titled 'Turkish Version of the UCLA Prostate Cancer Index' on Feb. 26.

Study Type: Observational [Patient Registry]

Primary Sponsor: Lokman Hekim University

Condition: Prostate Cancer (Diagnosis) Quality of Life Reliability Validity UCLA Prostate Cancer Index

Intervention: Other: Questionnaires

Recruitment Status: Not recruiting

Date of First Enrollment: January 20, 2022

Target Sample Size: 115

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07448545

Published by HT Digital Content Services with permission from Health Daily Digest....